Shared Solutions for patients with tardive dyskinesia (TD)

Reach out to us, we’ll handle the details

Shared Solutions®                  offers patient                  support. Support,                  knowledge,                  answers.
Shared Solutions® campaign image. Woman in lab coat speaking on phone.

Shared Solutions provides ongoing patient support by covering the “3 A’s”:

Flag Icon.

ACCESS—We help navigate hurdles that might stop your patient from accessing treatment

  • Benefit verification and navigation (Commercial, Medicare Part D, and Medicaid)
  • Prior authorization and appeals
  • Pharmacy identification and referral, even if you have a pharmacy preference

Piggy Bank Icon.

AFFORDABILITY—We help patients to identify financial assistance offerings

  • Free Trial Vouchers are available to all new TD and HD chorea patients for first 4 weeks of treatment
  • Copay coupons are available to eligible, commercially insured patients—as little as $0 copay per month

Calendar Icon.

ADHERENCE—We help patients start and stay on treatment1

  • Assist with managing dosing schedules and set treatment expectations
  • Proactive adherence communication from the first prescription
  • On-call nurse support throughout a patient’s treatment with AUSTEDO

Start the Shared Solutions process by:

Number 1 Icon.

Downloading and completing the Prescription and Service Request Form (PSRF) or requesting one from your rep

  • Remember to secure patient authorization by obtaining the patient’s signature on the PSRF, or by having the patient enroll online at


Number 2 Icon.

Utilizing the iAssist portal to enroll your patients (if available at your office)

  • The iAssist portal allows you to complete enrollments, prescriptions, and prior authorizations for your patients online, all on one platform. Register for a free iAssist account

Shared Solutions is available Monday-Friday from 8 AM to 8 PM CT. Call us at 1-800-887-8100

HD, Huntington’s disease.

REFERENCE: 1. Data on file. Parsippany, NJ: Teva Neuroscience, Inc.